EXANE DERIVATIVES - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2022$2,082,000
+6.7%
530.0%0.00%0.0%
Q1 2022$1,951,000
-19.2%
530.0%0.00%0.0%
Q4 2021$2,416,000
+27.6%
530.0%0.00%
Q3 2021$1,894,000
-93.9%
53
-96.8%
0.00%
-100.0%
Q2 2021$30,852,000
-19.2%
1,6420.0%0.01%
-36.4%
Q1 2021$38,191,000
+11.9%
1,6420.0%0.01%
+10.0%
Q4 2020$34,119,0001,6420.01%
Other shareholders
CYTOKINETICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders